Israel Englander Immatics N.V. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Immatics N.V. stock. As of the latest transaction made, Millennium Management LLC holds 50,000 shares of IMTX stock, worth $604,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,000

Previous 15,888 214.7%

Holding current value

$604,000

Previous $166,000 250.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$9.78 - $13.49 $415,425 - $573,014	42,477 Added 267.35%	58,365 $678,000
Q1 2024 May 15, 2024	BUY	$10.23 - $12.94 $162,534 - $205,590	15,888 New	15,888 $166,000
Q2 2023 Aug 14, 2023	BUY	$5.92 - $12.72 $6.87 Million - $14.8 Million	1,160,586 Added 457.32%	1,414,365 $16.3 Million
Q1 2023 May 15, 2023	BUY	$6.74 - $9.44 $663,034 - $928,641	98,373 Added 63.3%	253,779 $1.75 Million
Q4 2022 Feb 14, 2023	SELL	$8.05 - $11.58 $555,152 - $798,591	-68,963 Reduced 30.74%	155,406 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$3.31 - $13.06 $1.13 Million - $4.47 Million	-342,383 Reduced 60.41%	224,369 $2.24 Million
Q2 2022 Aug 15, 2022	BUY	$6.0 - $9.37 $3.18 Million - $4.96 Million	529,325 Added 1414.29%	566,752 $4.94 Million
Q1 2022 May 16, 2022	BUY	$6.64 - $12.85 $89,640 - $173,475	13,500 Added 56.42%	37,427 $299,000
Q3 2021 Nov 15, 2021	SELL	$11.58 - $15.46 $614,863 - $820,879	-53,097 Reduced 68.94%	23,927 $311,000
Q2 2021 Aug 16, 2021	BUY	$10.43 - $12.81 $803,360 - $986,677	77,024 New	77,024 $894,000
Q1 2021 May 17, 2021	SELL	$10.24 - $14.6 $1.05 Million - $1.49 Million	-102,309 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.67 - $12.05 $802,503 - $1 Million	82,989 Added 429.55%	102,309 $1.1 Million
Q3 2020 Nov 16, 2020	BUY	$8.73 - $15.15 $168,663 - $292,698	19,320 New	19,320 $205,000

Others Institutions Holding IMTX

# of Institutions

Shares Held

76.6M

Call Options Held

571K

Put Options Held

210K

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $921M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account